CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | Ho Carole Chief Medical Officer | Grant or award | +22,500 | 110,597 | ||
| 2022-08-09 | Schuth Alexander O. COFO and Secretary | Grant or award | +22,500 | 121,458 | ||
| 2022-07-25 | Tessier-Lavigne Marc Director | Sale | −19,800 | $35.60 | $705K | 1,950,556 |
| 2022-07-25 | Tessier-Lavigne Marc Director | Sale | −200 | $36.15 | $7K | 1,950,356 |
| 2022-07-19 | Krognes Steve E. Director | Option exercise | +62,500 | $0.68 | $43K | 151,721 |
| 2022-07-19 | Krognes Steve E. Director | Option exercise · Stock Option (right to buy) | −62,500 | 0 | ||
| 2022-06-24 | Tessier-Lavigne Marc Director | Returned to the company | −39,984 | $30.53 | $1.2M | 1,977,122 |
| 2022-06-24 | Tessier-Lavigne Marc Director | Returned to the company | −6,766 | $31.08 | $210K | 1,970,356 |
| 2022-06-23 | Tessier-Lavigne Marc Director | Returned to the company | −13,250 | $31.10 | $412K | 2,017,106 |
| 2022-06-02 | Schenkein David P Director | Grant or award | +5,986 | 11,313 | ||
| 2022-06-02 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | Klein Peter S Director | Grant or award | +5,986 | 11,313 | ||
| 2022-06-02 | Klein Peter S Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | Tessier-Lavigne Marc Director | Grant or award | +5,986 | 2,030,356 | ||
| 2022-06-02 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | Cole Douglas G. Director | Grant or award | +5,986 | 22,348 | ||
| 2022-06-02 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | SATO VICKI L Director | Grant or award | +5,986 | 142,149 | ||
| 2022-06-02 | SATO VICKI L Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | Cook Jennifer E. Director | Grant or award | +5,986 | 11,313 |
Page 15 of 53 · 1,043 trades